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Ionizing radiation modulates 
human macrophages towards 
a pro-inflammatory phenotype 
preserving their pro-invasive and 
pro-angiogenic capacities
Ana Teresa Pinto1,2,3, Marta Laranjeiro Pinto1,2,4, Ana Patrícia Cardoso1,2,3, Cátia Monteiro1,2, 
Marta Teixeira Pinto1,5, André Filipe Maia1,6, Patrícia Castro1,5, Rita Figueira7, 
Armanda Monteiro7, Margarida Marques7, Marc Mareel8, Susana Gomes dos Santos1,2,4, 
Raquel Seruca1,5,9, Mário Adolfo Barbosa1,2,4, Sónia Rocha10 & Maria José Oliveira1,2,9
In order to improve the efficacy of conventional radiotherapy, attention has been paid to immune 
cells, which not only modulate cancer cell response to therapy but are also highly recruited to tumours 
after irradiation. Particularly, the effect of ionizing radiation on macrophages, using therapeutically 
relevant doses, is not well understood. To evaluate how radiotherapy affects macrophage behaviour 
and macrophage-mediated cancer cell activity, human monocyte derived-macrophages were subjected, 
for a week, to cumulative ionizing radiation doses, as used during cancer treatment (2 Gy/fraction/day). 
Irradiated macrophages remained viable and metabolically active, despite DNA damage. NF-kappaB 
transcription activation and increased Bcl-xL expression evidenced the promotion of pro-survival 
activity. A significant increase of pro-inflammatory macrophage markers CD80, CD86 and HLA-DR, but 
not CCR7, TNF and IL1B was observed after 10 Gy cumulative doses, while anti-inflammatory markers 
CD163, MRC1, VCAN and IL-10 expression decreased, suggesting the modulation towards a more pro-
inflammatory phenotype. Moreover, ionizing radiation induced macrophage morphological alterations 
and increased their phagocytic rate, without affecting matrix metalloproteases (MMP)2 and MMP9 
activity. Importantly, irradiated macrophages promoted cancer cell-invasion and cancer cell-induced 
angiogenesis. Our work highlights macrophage ability to sustain cancer cell activities as a major concern 
that needs to be addressed to improve radiotherapy efficacy.
Radiation therapy is a widely used and highly cost effective cancer treatment modality1,2. The biological principle 
of its application relies mainly on the direct effect on cancer cells, as they usually exhibit higher proliferative rates 
and impairment in DNA repair mechanisms, when compared to host cells3. Although physics and technological 
evolution in the field of radiotherapy, involving new imaging modalities and more advanced software/equipment, 
have largely contributed to improve local control, it is necessary to improve radiotherapy targeting, control disease 
progression and predict treatment outcome4,5. To achieve the desired effectiveness, new therapeutic strategies, 
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administered concomitantly, before or after radiotherapy, are required6. The key may rely on a better understanding 
of the effect of ionizing radiation on tumour stromal cells, as they are crucial for disease progression and treatment 
outcome, and are also irradiated7–10. Ionizing radiation-induced cancer cell death releases death-signals, which 
lead to the recruitment of more immune cells, including monocytes which differentiate into macrophages at the 
injured region11. Within the different immune cells present at the tumour microenvironment, macrophages are 
particularly relevant, as they constitute, in many tumours, the major inflammatory stromal component and are 
also known as obligate partners for cancer cell migration, invasion and metastasis12,13. Due to their sophisticated 
phagocytic ability, macrophages perform a crucial role in clearing dying cells, contributing to the induction of 
tolerance, or stimulation of adaptive antitumour immunity11,14.
Nevertheless, it is not well understood how ionizing radiation, namely clinically relevant doses, directly affects 
macrophage behaviour as well as macrophage regulation of cancer progression. Till now a clear limitation on 
determining the clinical effect of ionizing radiation on elements of the tumour microenvironment are the model 
systems analysed and the dose of radiation used. Ionizing radiation for cancer treatment is usually delivered in a 
multi-fractionated regimen, with daily doses of typically 2 Gy (5× /week), often delivered during several weeks15. 
However, the majority of the studies aiming to reveal the effect of ionizing radiation on macrophages are performed 
in mouse models and make use of single, low (< 0.1 Gy) or moderate (0.1 Gy–1 Gy) doses16–20, thus not relevant 
in a human clinical context.
The present work aims to reveal the effect of fractionated ionizing radiation on human macrophages, mimick-
ing a week of cancer patients’ treatment. In order to achieve this, human monocyte-derived macrophages were 
differentiated in the presence of M-CSF, a factor involved in the recruitment of monocytes to the tissues, and 
exposed to cumulative ionizing radiation doses of 2 Gy each, up to 10 Gy. A plethora of functions in macrophages 
was then characterized. We demonstrate that irradiated macrophages are viable and metabolically active, activate 
NF-κ B, exhibit a reduced anti-inflammatory profile, increased phagocytosis and unaltered MMP-2 and 9-mediated 
proteolysis. We also evidenced that irradiated macrophages are still able to promote tumour cell invasion and angi-
ogenesis. Overall, our work adds novelty to the current literature and reinforces the idea of targeting macrophage 
differentiation and/or their molecular targets as a complementary strategy to improve radiotherapy efficacy.
Results
Irradiated macrophages are viable and metabolically active, despite DNA damage. To confirm 
DNA damage induced by the fractionated irradiation protocol, 10 Gy irradiated macrophages were fixed and 
immunostained for phosphorylated H2AX (Ser139) (γ H2AX), a sensitive marker of DNA double-strand breaks 
(DSBs)21. Immunofluorescence images and respective quantification indicated that a significantly (P < 0.01) 
higher percentage (87.17 ± 7.99%) of irradiated macrophages presented γ H2AX foci, in comparison to non-ir-
radiated ones (6.85 ± 1.03%) (Fig. 1A). Upon ionizing radiation exposure, DNA damage signals are generally 
sensed and propagated through a kinase cascade, including Ataxia Telangiectasia Mutated Kinase (ATM) and also 
Checkpoint kinase 2 (Chk2)22. Therefore, Chk2 expression and phosphorylation status were evaluated by western 
blot analysis. Chk2 activation was consistently observed in all donors at 1, 6 and 24 h after cumulative ioniz-
ing radiation doses (2, 6 and 10 Gy) (Fig. 1B). This data confirms that the irradiation protocol applied induced 
macrophage DNA damage, from single to several cumulative doses, and that the triggered signalling response 
involves Chk2 activation.
Depending on the level of radiation-induced DNA damage, cell death may or not occur22. Apoptosis is known 
as the major cell death modality induced by ionizing radiation in cells from the myeloid lineage, which is com-
posed by progenitor and mature effector myeloid cells, such as macrophages, dendritic cells, erythrocytes and 
platelets23–25. In the last years, a heterogeneous population of immature myeloid cells with immunosuppressive 
properties, termed myeloid-derived suppressor cells (MDSCs), has been defined26. Together with macrophages, 
this population is frequently recruited into tumours after ionizing radiation exposure and less radiosensitive than 
other lymphocyte subsets27–30.
Complementary approaches to detect cell apoptosis may include evaluation of several cellular aspects, such 
as caspase activation, cell morphology and mitochondrial status31. If apoptosis was occurring in irradiated mac-
rophages, effector caspases, those responsible for the apoptosis execution phase, such as caspase-7, should be 
functionally activated, this is proteolytically cleaved31. Therefore, caspase-7 expression was evaluated by western blot 
analysis, using an antibody which detects both the full length caspase-7 (35 kDa) and the large fragment of cleaved 
caspase-7 (20 kDa) (Fig. 1C). We demonstrated that there was no caspase-7 cleavage in irradiated macrophages. 
Additionally and focusing on the strongest cumulative dose (10 Gy) (6 h time point) (Supplementary Fig. S1), we 
confirmed, by using a positive control, that caspase-7 was not being cleaved in irradiated macrophages. At the same 
time, we also evaluated the cleavage of caspase-3, which is is a critical executioner of apoptosis31, and the cleavage 
of PARP, a substrate of several cell death proteases32, including caspase-3 (Supplementary Fig. S1). The antibody 
which detects the full length caspase-3 (35 kDa) also recognizes the large fragment of cleaved caspase-3 (17 kDa). 
Positive controls for caspase-3 and -7 activation as well as for PARP cleavage are presented in this western blot 
panel. As demonstrated by membrane overexposure, no cleavage of caspase-3/– 7 nor even of PARP were observed 
in irradiated macrophages, suggesting that apoptosis was not occurring.
In order to identify apoptosis-related morphological features in macrophages after exposure to cumulative ion-
izing radiation doses, cells were observed and photographed after each irradiation dose. No apoptotic signs, such 
as cell shrinkage, pyknosis or loss of membrane integrity31, were observed in 10 Gy irradiated and non-irradiated 
macrophages, suggesting that both populations were similarly viable (Fig. 1D).
To complement previous observations, macrophage mitochondrial function was evaluated 20 h after exposure 
to 2, 6 and 10 Gy cumulative doses, using the resazurin reduction assay (Fig. 1E). Results evidenced that, inde-
pendently of the dose, ionizing radiation did not affect macrophage metabolic activity.
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Figure 1. Irradiated human monocyte-derived macrophages are viable and metabolically active, despite 
DNA damage. (A) Radiation-induced macrophage DNA damage is demonstrated by immunocytochemistry 
for Ser139-phosphorylated H2AX (γ H2AX) (red), while nuclei were counterstained with DAPI (blue). Scale 
bar represents 20 μ m. Graph indicates the percentage of macrophages (n = 3 and 400 cells/donor counted) 
exhibiting γ H2AX foci. Data was analysed with paired t-test. **P < 0.01. (B) Western blot analysis of total and 
phosphorylated Chk2 (Thr68) expression on non-irradiated (− ) or irradiated (2, 6 and 10 Gy) (+ ) macrophages 
(n = 3), upon 1, 6 and 24 h. (C) Western blot analysis of caspase-7 expression on non-irradiated (− ) or 
irradiated (2, 6 and 10 Gy) (+ ) macrophages (n = 3), upon 1, 6 and 24 h. In all Western blots β -actin was used 
as loading control. (D) Brightfield microscopic images of non-irradiated (0 Gy) and irradiated macrophages 
(10 Gy). Scale bar represents 100 μ m. (E) Quantification of the metabolic activity of irradiated macrophages (2, 
6 or 10 Gy) (n = 8), normalized to the activity of non-irradiated ones, and expressed as percentage. One-sample 
t-test was performed.
www.nature.com/scientificreports/
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Overall, we concluded that irradiated macrophages are viable and metabolically active, and do not activate 
apoptosis, despite radiation-induced DNA damage.
Ionizing radiation activates macrophage pro-survival and NF-κB signalling path-
way. Considering macrophage survival following ionizing radiation exposure, a typical radiation-induced 
survival pathway mediated by NF-κ B33, was next investigated. Western blot analysis for the five NF-κ B family 
subunits, RelA, RelB, cRel, p52/p100 and p50/p105 (Fig. 2A) as well as for Iκ Bα (Supplementary Fig. S2), a 
NF-κ B inhibitor, were performed. Densitometry analysis (Supplementary Fig. S3) confirmed that ionizing radi-
ation increased the expression of RelB at every time points in every donors and tend to slightly increase cRel 
expression (Supplementary Fig. S3A). Additionally, ionizing radiation also tend to slightly increase p100 process-
ing, as suggested by a reduced p52/p100 ratio at 2 and 6 Gy. No major alterations were found in phRel/RelA and 
p105/p50 levels. Moreover, alterations in RelB suggested that ionizing radiation upregulates macrophage NF-κ B, 
mainly through the non-canonical pathway. As RelB was the most consistently upregulated subunit in response to 
radiation, we next confirmed RelB nuclear translocation, by evaluating its expression, in nuclear and cytoplasmic 
extracts, 6 h after 10 Gy cumulative dose (Fig. 2B). In fact, ionizing radiation increased RelB nuclear expression 
(Supplementary Fig. S3B), suggesting its nuclear translocation and subsequent activation. As NF-κ B can induce 
the expression of anti-apoptotic proteins, such as Bcl2 and Bcl-xL34, we evaluated the expression of these targets 
after macrophage irradiation (2, 6 and 10 Gy) (Fig. 2C). The most relevant alteration was the Bcl-xL increased 
expression, particularly at 10 Gy (Supplementary Fig. S3C). The increase was visible at 1 h and sustained after 
6 h, suggesting induction of macrophage pro-survival activity. Since Bcl-xL maximum expression tends to occur 
after 10 Gy, all subsequent experiments were performed with macrophages submitted to this cumulative ionizing 
radiation dose.
Ionizing radiation induces a reduction in anti-inflammatory macrophage phenotype. To evalu-
ate the effect of ionizing radiation on macrophage polarization profile, we characterized the pattern of expression 
of pro- or anti-inflammatory cytokines/chemokines and cell surface receptors, by a combination of quantitative 
Figure 2. Ionizing radiation induces macrophage NF-κB activation and increases Bcl-xL expression. 
(A) Evaluation of RelA phosphorylation (Ser536) and RelB, cRel, p100/p52 and p105/p50 subunit expression, 
1 and 6 h after irradiation (2, 6 and 10 Gy). (B) RelB nuclear translocation 6 h after macrophage irradiation 
(10 Gy). Histone deacetylase 1 (HDAC1) and β -actin were used as loading controls for nuclear and cytoplasmic 
fractions, respectively. (C) Evaluation of Bcl2 and Bcl-xL expression after macrophage irradiation. Western 
blot images are representative of protein expression/phosphorylation status in distinct donors (at least n = 4), 
evaluated in two independent experiments.
www.nature.com/scientificreports/
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real-time PCR, flow cytometry and ELISA. Ionizing radiation induced a significant increase (P < 0.05) of CD80 
expression, but not of other pro-inflammatory gene markers. In fact, IL6 and CCL2 were significantly downregu-
lated (P < 0.01) after macrophage irradiation (Fig. 3A). Furthermore, all anti-inflammatory gene markers tested, 
CD163, MRC1 and VCAN were significantly downregulated (P < 0.05 or P < 0.01) upon irradiation (Fig. 3A). To 
investigate how these changes could translate into cell surface receptor expression, flow cytometry was then per-
formed. Results evidenced that ionizing radiation significantly increased HLA-DR (P < 0.01) and CD86 (P < 0.05) 
(macrophage pro-inflammatory markers), and tend to decrease CD163 (macrophage anti-inflammatory marker), 
but did not alter the expression of the monocyte/macrophage lineage marker CD14 (Fig. 3B). To further complete 
the polarization profile analysis, levels of pro-(IL-6 and IL-12/IL-23(p40)) and anti-inflammatory (TGF-β 1 and 
IL-10) cytokines were evaluated by ELISA, using conditioned medium (CM) from non-irradiated (0 Gy) and irra-
diated (10 Gy) macrophages, normalized to protein concentration (Fig. 3C). Interestingly, only IL-10 levels were 
significantly downregulated (P < 0.01) by ionizing radiation. IFN-γ and TNF-α levels were also investigated, but 
Figure 3. Irradiated macrophages present a reduced anti-inflammatory phenotype. (A) mRNA expression 
profile of pro-(CXCL8, CD80, IL1B, TNF, CCR7, CCL2, IL6) and anti-inflammatory (CD163, MRC1, VCAN) 
macrophage markers, by real-time PCR, 20 h after 10 Gy. Graphs represent mRNA expression of irradiated 
macrophages compared to non-irradiated ones (dotted line) (at least n = 7 per marker). β -actin was used 
as housekeeping gene. Wilcoxon signed rank test was used to compare the median of each dataset against a 
hypothetical median value of 1. (B) Expression of a monocyte/macrophage lineage (CD14), pro-(HLA-DR and 
CD86) and anti-inflammatory (CD163) macrophage markers was determined, by flow cytometry, 20 h after 
irradiation (at least n = 6 per marker). Paired t-test was used for statistical analysis. (C) Levels of pro-(IL-6, 
IL-12/IL-23(p40)) and anti-inflammatory (TGF-β 1 and IL-10) cytokines were determined in macrophage CM 
(n = 9) by ELISA, 20 h after irradiation. Data was normalized to protein concentration. Wilcoxon matched pair 
test was used for statistical analysis. *P < 0.05, **P < 0.01. Median is represented by the horizontal line inside 
the box plots, while the average is indicated by a “+ ”. In IL-6 and IL-10 graphics outliers are also indicated.
www.nature.com/scientificreports/
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were undetectable for both macrophage populations. Altogether, this data suggests that ionizing radiation directs 
macrophages towards a reduced anti-inflammatory phenotype, without achieving however a complete classical 
pro-inflammatory profile.
Upon exogenous stimulation, irradiated macrophages polarize towards pro- or 
anti-inflammatory phenotypes. Unstimulated M-CSF differentiated macrophages typically exhibit a 
more anti-inflammatory-like phenotype, but they are able to polarize towards a pro- or an anti-inflammatory 
phenotype, after proper exogenous stimulation35,36. The functional response to external stimuli, termed plas-
ticity, is one of the major hallmarks of the mononuclear phagocyte system37. To assess how ionizing radiation 
affects macrophage plasticity, we evaluated whether irradiated macrophages were still able to polarize towards a 
pro- or an anti-inflammatory phenotype, upon proper exogenous stimulation. Therefore, upon 10 Gy cumulative 
dose exposure, macrophages were stimulated for 20 h with LPS (100 ng/mL) and IFN-γ (20 ng/mL), towards a 
pro-inflammatory phenotype, or with M-CSF (10 ng/mL) and IL-10 (20 ng/mL), towards an anti-inflammatory 
one. The expression of pro- and anti-inflammatory cell surface markers and cytokines/chemokines was evaluated 
by flow cytometry (Fig. 4A) and ELISA (Fig. 4B), respectively. Comparison between exogenously stimulated 
(LPS/IFN-γ or M-CSF/IL-10) non-irradiated (0 Gy) and irradiated (10 Gy) macrophages indicated that ionizing 
radiation did not affect macrophage ability to polarize towards a pro- or an anti-inflammatory phenotype, upon 
proper exogenous stimuli. LPS/IFN-γ -stimulated macrophages (both non-irradiated and irradiated) present 
higher levels of pro-inflammatory markers such as HLA-DR, CD86, TNF-α , IL-6 and IL-12/IL-23 (p40), being 
the last four significantly different (from P < 0.05 to P < 0.001), when compared to M-CSF/IL-10-stimulated mac-
rophages (Fig. 4A,B). On the other side, LPS/IFN-γ -stimulated macrophages tend to present lower levels of the 
anti-inflammatory marker CD163, comparing to M-CSF/IL-10-stimulated macrophages (Fig. 4A). Our results 
evidenced that, contrary to expectations, the pro-inflammatory stimuli (LPS/IFN-γ ) also induced higher levels of 
immunosuppressive IL-10 cytokine than the anti-inflammatory ones (M-CSF/IL-10). However, this phenomenon 
was also previously reported in M-CSF-conditioned dendritic cell precursors, which exhibit a rapid IL-10 release 
upon LPS stimulation and may therefore participate in the modulation of inflammation and immune response38.
Figure 4. Upon exogenous stimulation, irradiated macrophages polarize towards a pro- or an anti-
inflammatory phenotype. Non-irradiated and 10 Gy irradiated macrophages (n = 6) were stimulated, for 
20 h, with LPS (100 ng/ml) and IFN-γ (20 ng/ml) towards a pro-inflammatory, or with M-CSF (10 ng/ml) and 
IL-10 (20 ng/ml) towards an anti-inflammatory phenotype. (A) Expression of monocyte/macrophage lineage 
(CD14), pro-(HLA-DR and CD86) and anti-inflammatory (CD163) macrophage markers was determined by 
flow cytometry. (B) Macrophage CM levels of pro-(TNF-α , IL-6, IL-12/IL-23(p40)) and anti-inflammatory 
(TGF-β 1 and IL-10) cytokines were determined by ELISA. Data was normalized to protein concentration. 
Paired t-test and one-way ANOVA were used for statistical analysis. *P < 0.05, **P < 0.01, ***P < 0.001. Median 
is represented by the horizontal line inside the box plots, while the average is indicated by a “+ ”.
www.nature.com/scientificreports/
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Interestingly, irradiated macrophages stimulated with LPS/IFN-γ presented significantly (P < 0.05) higher 
levels of HLA-DR, when compared to their non-irradiated counterparts (Fig. 4A). On the other hand, under 
stimulation with M-CSF/IL-10, irradiated macrophages tend to exhibit lower CD163 and higher HLA-DR levels, 
when compared to non-irradiated macrophages (Fig. 4A,B). Also, irradiated macrophages polarized towards a 
pro- or an anti-inflammatory phenotype presented a significant decrease (P < 0.05) in IL-10 levels, when compared 
to non-irradiated and also exogenous stimulated ones (Fig. 4B). Altogether, these results demonstrate that, upon 
exogenous stimulation, irradiated macrophages are still able to polarize towards a pro- or an anti-inflammatory 
phenotype. However, ionizing radiation by itself tends to promote the pro-inflammatory phenotype.
Ionizing radiation induces macrophage morphological alterations and increases their phago-
cytic rate, without altering MMP-2 and MMP-9 activities. In order to characterize morphological 
changes, macrophage area and aspect ratio were determined 1 h after exposure to 10 Gy (Fig. 5A). Results indi-
cated that irradiated macrophages presented a significantly higher (P < 0.05) cell area (2,471 ± 513.3 μ m2) and 
tend to increase cell aspect ratio (quotient between major and minor cell axes) (2.38 ± 0.63), when compared to 
non-irradiated ones (area 2,047 ± 616.3 μ m2 and aspect ratio 1.72 ± 0.24).
Besides functional and morphological plasticity, other features like phagocytic ability and proteolysis are 
also characteristic of macrophages39. To evaluate the effect of ionizing radiation on macrophage phagocytic 
ability, non-irradiated and 10 Gy irradiated macrophages were incubated, for 1 h, with FITC-labelled and killed 
Staphylococcus (S.) aureus particles. Results revealed that ionizing radiation significantly increased (P < 0.01) the 
percentage of macrophages able to phagocyte S. aureus particles (Fig. 5B).
The impact of ionizing radiation on the activity of MMP-2 and MMP-9, two matrix metalloproteases involved in 
the promotion of cancer cell invasion and angiogenesis40, was determined by gelatin zymography. Using 1 μ g of pro-
tein from macrophage CM, no differences in pro-MMP-9 proteolytic activity were found, between non-irradiated 
and 10 Gy irradiated macrophages (Fig. 5C). The same conclusion was extended to MMP-9 and pro-MMP-2 pro-
teolytic bands, when 15 μ g of macrophage CM protein were loaded. Our results evidence that ionizing radiation 
induces macrophage morphologic alterations and increases their phagocytic rate, without affecting macrophage 
MMP-2 and MMP-9 proteolytic activities.
Irradiated macrophages promote cancer cell invasion and angiogenesis. To investigate the effect 
of ionizing radiation on macrophage pro-invasive cancer cell activity, non-irradiated or 10 Gy irradiated mac-
rophages and irradiated colorectal cancer cells were confronted on Matrigel invasion assays (Fig. 6A). Irradiated 
as non-irradiated macrophages significantly promoted (P < 0.001 or P < 0.01) the invasion of irradiated RKO 
Figure 5. Ionizing radiation increases macrophage area, aspect ratio and phagocytic rate, but does not 
alter MMP-2 and -9 activities. (A) Actin (green) and tubulin (red) stainings of non-irradiated and 10 Gy 
irradiated macrophages (n = 4). Quantification of cell area and aspect ratio was performed using Fiji software. 
Scale bar indicates 20 μ m. (B) Phagocytic ability of non-irradiated and 10 Gy-irradiated macrophages (n = 5) 
was determined after 1 h incubation with FITC-labelled (green) Staphylococcus aureus particles. F-actin was 
stained with rhodamine phalloidin (red). The percentage of macrophages able to phagocyte S.aureus particles 
was quantified using Fiji software. Scale bar indicates 20 μ m. (C) MMP-2 and -9 activity was evaluated by 
gelatin zymography, using 1 and 15 μ g of protein from CM of non-irradiated and 10 Gy-irradiated macrophages 
(n = 10). White bands of proteolytic activity were revealed on a Coomassie Blue-stained gelatin gel. All data was 
analysed with paired t-test. **P < 0.01, ***P < 0.001. Median is represented by the horizontal line inside the box 
plots, while the average is indicated by a “+ ”.
www.nature.com/scientificreports/
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cells. To clarify if macrophage pro-invasive ability was dependent on the presence of irradiated colorectal cancer 
cells, we used non-irradiated RKO cells. Herein, we verified the same effect previously observed indicating that 
irradiated macrophages do not lack the ability to promote cancer cell invasion. Moreover, we also observed that 
irradiation of RKO cells alone significantly decrease (P < 0.05) its invasive potential. We could indeed predict 
that RKO cell invasive potential was going to be highly affected by radiation exposure due to the RKO intrinsic 
radiosensitivity, previously reported in the literature. An accumulation of about 70% of RKO cells was described 
in G2/M-phase 16 ± 24 h after 12 Gy irradiation in pH 7.5 medium41. RKO cells were also included in a group 
of radiosensitive cells, upon evaluation of the clonogenic survival of 27 human tumour cell lines after ionizing 
radiation exposure42.
In order to investigate the effect of irradiated macrophages on cancer cell-induced angiogenesis, a chick embryo 
chorioallantoic membrane (CAM) assay was performed. CM from both non-irradiated and 10 Gy irradiated mac-
rophages significantly promoted (P < 0.05) RKO-induced angiogenesis (Fig. 6B). No differences were observed 
between RKO cells treated with CM derived from non-irradiated and irradiated macrophages. Altogether, Matrigel 
invasion and CAM-based assays demonstrated that, in the present experimental context, ionizing radiation per se 
was not able to restrain macrophages’ endogenous ability to promote cancer cell invasion and cancer cell–induced 
angiogenesis, which constitute two main hallmarks of cancer3.
Discussion
The present work aims to understand the effect of ionizing radiation on human macrophages, as they are important 
components of the tumour microenvironment, and also highly recruited into tumours during radiation therapy43. 
The recurrent use of mouse models and lack of clinically relevant doses in other studies have not allowed a full 
understanding of this effect16–20. In the present study, we characterized, for the first time, the response of human 
primary macrophages to cumulative ionizing radiation doses, using the same fractionated scheme as used during 
Figure 6. Ionizing radiation does not affect macrophage ability to promote cancer cell invasion and 
cancer cell-mediated angiogenesis. (A) Matrigel invasion assays were established confronting RKO cells 
(upper compartment) and macrophages (lower compartment) after being separately exposed or not to 10 Gy 
cumulative ionizing radiation dose. The six possible combinations are represented in the scheme. Invasive 
cells were counterstained with DAPI and counted on the microscope. (B) RKO cells were inoculated, for 72 h, 
with CM from non-irradiated or 10 Gy irradiated macrophages, in rings (inoculation areas), on top of CAM. 
The comparison of RKO+ CM Mac 0 Gy versus RKO+ CM Mac 10 Gy was evaluated in two rings within the 
same fertilized egg (n = 18), while the condition RKO+ RPMI was performed in a single distinct egg (n = 16). 
Analysis of RKO-induced angiogenesis was performed through quantification of the number of new vessels in 
control and experimental conditions. ANOVA analysis demonstrated a significant difference between groups. 
*P < 0.05, **P < 0.01, ***P < 0.001. The median is represented by the horizontal line inside the box plots, while 
the average is indicated by a “+ ”.
www.nature.com/scientificreports/
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cancer patients’ treatment (2 Gy/fraction/day), up to 10 Gy cumulative dose. As a model, we used M-CSF-cultured 
macrophages, differentiated from peripheral-blood monocytes, as it is considered the predominant in vitro sys-
tem to study human tissue macrophages44. M-CSF is a growth factor involved in the recruitment of monocytes/
macrophages to tissues and also in the regulation of macrophage function within tumours45. Taking into account 
that the cellular radiation response is a complex process46, several features like DNA damage, NF-κ B signalling 
pathway, polarization profile, plasticity, phagocytosis, proteolysis and the ability to promote cancer cell activities, 
were evaluated in irradiated human macrophages.
Macrophage resistance to ionizing radiation was first reported in mouse models some decades ago47,48. 
Nowadays, it is recognized that human macrophages, similarly to regulatory T cells (Tregs), dendritic cells, Natural 
Killer (NK) cells and thrombocytes, as well as MDSCs, display a more radiation resistant phenotype than other 
immune cell populations, such as monocytes27,29,30,46. However, most of the studies were performed in mouse mac-
rophages irradiated with X-ray doses, which barely mimic the fractionated scheme used in cancer patients’ treat-
ment. Our results demonstrated that irradiated macrophages exhibited higher DNA damage, confirmed through 
increased H2AX phosphorylation, than non-irradiated ones. DNA damage induced by ionizing radiation is known 
to lead to Chk2-specific phosphorylation (Thr68) at sites of DSBs49. In agreement, we demonstrated that Chk2 
phosphorylation increased along time and according to the exposure doses. Despite DNA damage, irradiated mac-
rophages remain viable and metabolically active, leading to understand which survival pathways were activated. 
We focused on NF-κ B signalling, which is known to induce a pro-survival response in cells exposed to single 2 Gy 
doses33,50. Our results demonstrated that RelB expression was consistently increased after macrophage exposure 
to 2, 6 and 10 Gy cumulative doses. RelB nuclear translocation suggested the involvement of the non-canonical 
NF-κ B pathway in radiation-induced macrophage response. Our data also demonstrated an increased expression 
of the anti-apoptotic Bcl-xL protein, which also contributes to the promotion of pro-survival activity. Interestingly, 
a recent study demonstrated that ionizing radiation induces RelB to activate Bcl-xL in cancer cells51.
NF-κ B transcription factors are not only important for cell survival upon irradiation, but are also considered 
major regulators of inflammation processes and, particularly in macrophages, their activation is required for 
the anti- to pro-inflammatory phenotype transition52–54. Radiation-induced NF-κ B alterations in macrophages 
led to the characterization of macrophage inflammatory status upon irradiation, which data was summarized 
in the scheme of Fig. 7. In the present study, 10 Gy cumulative ionizing radiation dose significantly decreased 
both anti-inflammatory gene markers (CD163, MRC1, VCAN) and the immunosuppressive cytokine IL-10, and 
increased HLA-DR and CD86 expression of M-CSF differentiated macrophages (Fig. 7). Additionally, we also 
demonstrated that bacterial phagocytosis, a classical feature of pro-inflammatory macrophages, was found to be 
significantly increased in irradiated macrophages. In fact, mouse macrophages subjected to 8 Gy single dose were 
also described to slightly enhance phagocytosis of inert latex beads55. Together, our data supports the hypothe-
sis that ionizing radiation may drive macrophages towards a pro-inflammatory phenotype. Although irradiated 
macrophages exhibited increased CD80 expression, other classical pro-inflammatory markers, like IL1B, TNF 
and IL6 were unaltered, downregulated, or undetectable at the cytokine level. This suggests that irradiated mac-
rophages did not reach a classical pro-inflammatory phenotype, despite the observed reduction of their original 
anti-inflammatory-like phenotype. The mechanism behind this shift in macrophage phenotype may indeed rely 
on radiation-induced NF-κ B alterations, particularly in RelB subunit as its expression is increased in irradiated 
macrophages. In fact, very recently, a switch of anti-inflammatory to pro-inflammatory macrophages was found to 
be directly mediated by RelB induction in M-CSF and TNF-stimulated osteoclast precursors56. However, further 
experiments are still required to confirm RelB involvement in macrophage anti-inflammatory phenotype reduction, 
suggested to occur after macrophage ionizing radiation exposure.
To simplify the understanding of our hypothesis, we represented the typical pro- and anti-inflammatory mac-
rophage profiles as two extremes of a continuous polarization spectrum (generally represented as a line). However, 
macrophage polarization has been revealed as a very complex and dynamic system and new representations are 
emerging as long as new knowledge in this area is coming out. Recently, Ruffell and Coussens summarized the 
macrophage polarization system as a circle, which does not consider pro- and anti-inflammatory macrophage 
profiles, but rather emphasize that macrophage functional roles (angiogenesis, cytotoxicity, stimulation, suppres-
sion or chemotaxis) (included in an inner circle) are dictated by the integration of multiple stimuli (represented 
in an outer circle)57. Therefore, we may speculate that ionizing radiation exposure could also constitute one of 
the distinct stimuli capable of polarizing macrophages into a different phenotype, which does not completely 
corresponds to a pro- or an anti-inflammatory one, but could rather include features from both phenotypes, as we 
demonstrated in this work, or even from other phenotypes still to be defined. Overall, our study defines, for the 
first time, a molecular profile for human macrophages subjected to cumulative ionizing radiation doses, empha-
sizing the important role of fractionated ionizing radiation doses, as used in radiotherapy, to direct macrophages 
towards a pro-inflammatory phenotype, which is recognized to be tumour cytotoxic37. According to the literature, 
the relation between ionizing radiation exposure and inflammatory response seems to be dependent not only on 
the cell type analysed and radiation quality, but mainly on the delivered dose58. Low doses (maximum of 12 Gy at 
≤ 1.0 Gy/fraction), usually applied in non-malignant disorders or received by normal tissues outside the tumour 
target volume, induce an anti-inflammatory phenotype, while higher doses (single doses ≥ 2 Gy, total doses ≥ 40 Gy) 
are reported to have a pro-inflammatory effect59,60. Most of the studies, aiming to reveal the role of irradiation on 
macrophage inflammatory status, are performed using in vitro or ex vivo mouse macrophages. Although mouse 
models have widely contributed to our understanding of ionizing radiation-induced effect on macrophages, it is 
also well recognized that mouse and human macrophages present many distinct features61. Particularly, mouse 
macrophages are high producers of nitric oxide (NO) and L-citrulline from L-arginine, via inducible nitric oxide 
synthase (iNOS) activation, while NOS and arginase activities in human macrophages are quite debatable62,63. These 
considerations should be taken into account when extrapolating data from one species to another.
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We have also demonstrated that irradiated macrophages are as able as their non-irradiated counterparts to 
promote RKO cancer cell invasion and cancer cell-induced angiogenesis. This is the first report demonstrating 
that, at least during the first week (5 days) of radiotherapy, human macrophages sustain its ability to promote 
cancer cell invasion and cancer cell-induced angiogenesis, which is a matter of concern. Nevertheless, we need to 
be cautious when extrapolating this data to the clinic, as during further neoadjuvant treatment the situation may 
change. Not only because cell response along treatment time may be different but also because in vivo other host 
cells and several environmental factors may contribute to tumour response to radiotherapy. As our team previously 
demonstrated, MMP activity is known to be an important factor for macrophage-mediated cancer cell invasion64. 
Therefore, the sustained promotion of cancer cell invasion by irradiated macrophages may be associated with the 
fact that MMP-2 and MMP-9 activity is not being affected by radiation exposure. Furthermore, we also showed 
that irradiated macrophages are still able to promote cancer cell-induced angiogenesis.
In summary, our work adds valuable data on characterization of a plethora of functions in human macrophages, 
subjected to cumulative ionizing radiation doses, as used during cancer patients’ treatment, which were not 
addressed before. We have characterized important aspects like plasticity, proteolysis, phagocytosis and cancer cell 
activity promotion. We demonstrated that human macrophages subjected to cumulative doses of ionizing radiation 
are viable, metabolically active and exhibit increased survival signalling, through NF-κ B activation and increased 
Figure 7. Schematic representation of the effect of ionizing radiation on human blood monocyte-derived 
macrophages. Two main macrophage functional polarization status are recognized: a pro-inflammatory, 
responsible for killing intracellular pathogens and antitumour activity, and an anti-inflammatory one, which 
induces tissue repair, angiogenesis and promotes tumour activity. Pro-inflammatory macrophages produce high 
levels of TNF-α , IL-6 and IL-1β cytokines and exhibit CD80, CD86, HLA-DR, CCR7 and NF-κ B increased 
expression, while anti-inflammatory ones express CD163, MRC1 and produce high levels of TGF-β 1 and 
IL-10 cytokines. In the present study, we demonstrated that irradiated macrophages exhibit a decrease of anti-
inflammatory (CD163, MRC1 and IL-10) and an increase of other pro-inflammatory (CD80, CD86, HLA-DR) 
markers. Although irradiated macrophages are more effective than non-irradiated ones at phagocytosis, a 
typical feature of pro-inflammatory macrophages, they fail to reach a classical pro-inflammatory phenotype, 
as they do not produce high levels of TNF-α , IL-6, IL-1β and CCR7. On the other hand, and similarly to 
their counterparts, irradiated macrophages are able to promote cancer cell invasion and cancer cell-induced 
angiogenesis. Our data suggests that M-CSF differentiated macrophages, exposed to cumulative ionizing 
radiation doses up to 10 Gy, exhibit a reduced anti-inflammatory-like phenotype, compared to non-irradiated 
ones, probably moving towards a pro-inflammatory phenotype. However, although irradiated macrophages 
exhibit characteristics from both pro- and anti-inflammatory phenotypes, they do not perfectly match to any of 
these typical profiles, appearing to acquire intermediate characteristics.
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Bcl-xL expression, despite DNA damage. Irradiated macrophages also present a reduced anti-inflammatory profile, 
increased phagocytosis and unaltered MMP-2 and -9-mediated proteolysis. Pro-inflammatory-like macrophages 
are known to be cytotoxic and exhibit antitumoural activities and may therefore contribute to the efficacy of local 
radiotherapy37. Our data also demonstrates that irradiation maintains macrophage ability to promote cancer cell 
invasion and cancer cell-induced angiogenesis. Overall, although radiotherapy mainly induces cancer cell death, 
other components of the microenvironment, particularly macrophages, are also irradiated and could persist still 
sustaining the activity of residual radioresistant cancer cells. Furthermore, this knowledge opens new perspectives 
for macrophage clinical targeting, prior, after or concomitantly to ionizing radiation, as a strategy to improve 
radiotherapy efficacy.
Material and methods
Ethics statement. In the present study, human monocytes were obtained from buffy coats, which are a 
highly leukocyte-enriched waste-product that results from a whole blood donation, from healthy blood donors. 
A collaboration protocol between our Institution and Centro Hospitalar São João (CHSJ), where blood donations 
of Portugal North region are performed, allows the use of these products for investigation purposes. All studies 
using this human material were approved by CHSJ Ethics Committee for Health (References 259 and 260/11), 
in agreement with the Helsinki declaration. Informed consent was obtained from all subjects before each blood 
donation.
Human monocyte isolation and macrophage differentiation. Human monocytes were iso-
lated as previously described64. Following this procedure, over 80% of isolated monocytes were found to be 
CD14-positive64. For monocyte-macrophage differentiation, 1.2 × 106 cells/9.6 cm2 (6-well plate) were cul-
tured in complete RPMI1640 medium with GlutaMax (Invitrogen) in the presence of 50 ng/mL of macrophage 
colony-stimulating factor (M-CSF) (ImmunoTools). Culture medium (1.5 mL/well) was replaced after one week 
and macrophage differentiation was completed 13 days after monocyte isolation, as at this stage macrophages 
were shown to provide a higher stimulus for cancer-cell invasion, than with shorter differentiation times64.
Cell culture. RKO (CRL-2577) cells, derived from a human colon carcinoma, were purchased from the 
American Type Culture Collection (ATCC). Cells were maintained at 37 °C, 5% CO2 humidified-atmosphere, 
in RPMI1640 (L-Glutamine) (Invitrogen) supplemented with 10% FBS (Lonza, Basel, Switzerland), 100 U/mL 
penicillin and 100 μ g/mL streptomycin (Invitrogen).
Ionizing radiation exposure. Prior irradiation, a dosimetry plan was established (ELEKTA CMS 
XiO v.4.7.0). Culture plates were submitted to a Computerized Tomography (CT) scan and the volume occu-
pied by two entire plates was defined as the target volume. Two beam fields, one anterior-posterior and other 
posterior-anterior, were arranged to deliver 2 Gy per fraction to this target volume. Inside the defined volume, the 
total dose varied from 198 cGy to 202 cGy. As the 4 cGy difference was not significant, the same dose was consid-
ered homogenously distributed through plates. To guarantee this uniform dose and to avoid the build-up region 
of the 18 MV photon beam, 5 water plates were added above, and 5 below the culture plates during irradiation. 
Medium was renewed before the first irradiation. Both macrophages and RKO cells were then exposed to 1–5 
cumulative ionizing radiation doses (2 Gy/fraction/day), for a week (Monday to Friday). Therefore, the maximum 
cumulative irradiation dose, equivalent to 5 fractions, totalized 10 Gy (Supplementary Fig. S4). Photon beam was 
produced by a PRIMUS (Siemens, Malvern, PA, USA) linear particle accelerator, used for human radiotherapy 
sessions, operated at 18 MV at the Radiotherapy Service of CHSJ. To avoid differences between non-irradiated 
and irradiated cells, caused by medium agitation during transport to/from the Radiotherapy Service, control cells 
were also transported, but were not radiation-exposed.
Cell viability. For a proper follow-up of macrophage during irradiation week, cells were carefully observed 
under a light microscope (Olympus) and daily pictures were taken. To complement this qualitative data, mac-
rophage metabolic activity was determined through resazurin reduction assay, which was considered a sensitive, 
reproducible and non-destructive assay to measure cell response to irradiation65. Briefly, 20 h after irradiation 
(2, 6 or 10 Gy), macrophages were incubated with resazurin redox dye (0.01 mg/mL) (Sigma-Aldrich) for 3 h 
at 37 °C and 5% CO2. Fluorescence intensity was measured (530 nm Ex/590 nm Em), using the multi-mode 
microplate reader Synergy MX (BioTek) and values were normalized to protein concentration in the CM, meas-
ured with detergent-compatible (DC) protein assay (BioRad). Data from irradiated macrophages was then com-
pared with the respective controls and expressed as percentage.
Protein extraction and Western Blot. Whole cell protein-extracts were performed 1, 6 and 24 h after 
irradiation (2, 6 and 10 Gy) (n = 4), using lysis buffer supplemented with a cocktail of proteases/phosphatases 
inhibitors, as previously described64. Nuclear/cytoplasmic extracts were performed 6 h after 10 Gy (n = 5), using 
appropriate lysis buffer [10 mM Hepes pH 7.9, 1.5 mM MgCl2, 10 mM KCL, 1 mM DTT, 0.1% Igepal, protease/
phosphatase inhibitors cocktail]. Cytoplasmic extracts were obtained after centrifugation at 14 000 rpm for 
10 min, at 4 °C. For nuclear extracts, pellets were resuspended in another lysis buffer [20 mM Hepes pH 7.9 , 
420 mM KCl , 1.5 mM MgCl2, 1 mM DTT, 25% Glycerol, protease/phosphatase inhibitors cocktail], rocked for 
15 min at 4 °C, centrifuged at 14 000 rpm for 15 min, and sonicated. Following SDS-PAGE, gels were transferred 
onto polyinylidine difluoride (PVDF) membrane, which were then incubated, for 1 h, with primary antibod-
ies against the following proteins: p105/p50, p100/p52 (Millipore), Bcl-xL (BD Biosciences), phospho-Iκ Bα 
(Ser32/36) (clone 5A5), Iκ Bα (clone 44D4), phospho-RelA (Ser536) (clone 93H1), Bcl-2 (clone 50E3), 
phospho-Chk2 (Thr68), Chk2, caspase-3, caspase-7, cleaved PARP (clone D64E10) (Cell Signalling), RelA, RelB, 
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cRel (Santa Cruz Biotechnology). Positive controls for caspase-3 and -7 activation as well as for PARP cleavage 
were used. Antibody against β -actin (clone 8H10D10) (Cell Signalling) was used to normalize protein expres-
sion. Goat anti-rabbit or horse anti-mouse-Horseradish peroxidase (HRP)-conjugated secondary antibodies (Cell 
Signalling) were used for 1 h, followed by ECL-Detection (Thermo Fisher Scientific). Densitometry analysis of 
western blot images from Fig. 2 was performed with Quantity One software (BioRad).
RNA extraction, cDNA preparation and quantitative PCR analysis. Total RNA, from 
non-irradiated or 10 Gy irradiated macrophages, was extracted using TriPure Isolation Reagent (Roche), 
according to manufacturer’s instructions. RNA was converted to cDNA using 150 U of SuperScript™ II 
Reverse Transcriptase, 1× first strand buffer, 10 mM DTT 0.1 M (Invitrogen), 0.5 mM dNTPs 10 mM (Bioron), 
8U of rRNasin (Promega) and RNase/DNase free water (Gibco). To evaluate mRNA expression levels of pro- 
and anti-inflammatory gene markers, quantitative PCR using Brilliant II Sybr green kit (Stratagene/Agilent 
Technologies) and specific MX3005P 96-well semi-skirted plates, were performed. Samples were analysed on 
the MX3005P qPCR platform (Stratagene/Agilent). The following primers, from Invitrogen, were used for 
RT-qPCR: CXCL8, F: 5′ -CCAGGAAGAAACCACCGGA-3′ , R: 5′ -GAAATCAGGAAGGCTGCCAAG-3′ ; 
IL1B, F: 5′-GGCAGGGAACCAGCATC-3′  , R: 5′-CCGACCACCACTACAGCAA-3′  ; TNF F: 5′- 
GGCTGGAGCTGAGAGATA-3′ , R: 5′ -CAGCCTTGGCCCTTGAAGA-3′ . Primer sets for ACTB (used as a 
normalizing gene), CXCL12 and CCL2 were obtained from Qiagen, while probes for CD80, CCR7, IL6, CD163, 
MRC1 and VCAN were from Applied Biosystems.
Macrophage polarization. After 10 Gy cumulative ionizing radiation exposure, macrophages were 
stimulated, during 20 h, with 100 ng/mL LPS (Sigma-Aldrich) plus 20 ng/mL IFN-γ (Immunotools) towards a 
pro-inflammatory phenotype (M1-like), or with 10 ng/mL M-CSF plus 20 ng/mL IL-10 (Immunotools) towards 
an anti-inflammatory (M2-like) one44.
Flow cytometry. For cell surface receptor expression analysis, non-irradiated and 10 Gy irradiated mac-
rophages, subjected or not to further cytokine-induced polarization, as above detailed, were kept on ice, washed 
with PBS, gently detached by scraping and resuspended in FACs buffer [PBS, 2% FBS (Lonza), 0.01% sodium 
azide]. Stainings with anti-human CD14-APC (clone MEM-18), HLA-DR-PE (MEM-12), CD86-FITC (clone 
BU63) (Immunotools) and CD163-PE (clone GHI/61) (R&D Systems) antibodies were performed in the dark 
for 30 min. After additional washing steps, macrophages were fixed for 15 min in 4% paraformaldehyde (PFA). 
Isotype-matched antibodies were used as negative controls, to define background staining. Cells were acquired 
on a FACS Calibur™ Flow Cytometer (BD Biosciences), using Cell Quest Software (collecting 1 × 104 cells). 
Analysis was performed with FlowJo software (v7.6.5). Mean fluorescent intensity was calculated by subtracting 
the respective isotype control intensity.
Enzyme-linked immunosorbent assay (ELISA). IL-6, IL-12/IL-23(p40), TNF-α , TGF-β 1 free active 
and IL-10 cytokine levels were determined, according to manufacturer’s instructions (BioLegend), in CM from 
non-irradiated and 10 Gy irradiated macrophages, subjected or not to further cytokine-induced polarization as 
above detailed. Briefly, 50 μ L of cell culture supernatant were added to a 96-well plate pre-coated with the cap-
ture antibody of interest. The soluble proteins bound to the capture antibody were detected using a biotinylated 
antibody, followed by an avidin-HRP conjugated solution. Finally, the addition of TMB substrate, resulted in a 
colour change, which intensity was proportional to the amount of antigen captured. Absorbance was then read at 
450 and 570 nm. Cytokine levels were determined by plotting values on a standard curve and normalizing them 
to CM protein concentration.
Immunocytochemistry. DNA damage and morphology were evaluated, by immunocytochemistry, in 
non-irradiated and 10 Gy irradiated macrophages (4 × 104). After 1 h, macrophages were fixed with 4% PFA 
for 20 min and immunocytochemistry procedure was then performed as previously described64. Macrophages 
were incubated with monoclonal antibodies for phosphorylated histone-H2AX (Ser139) (γ H2AX) (clone 
JBW301) (Millipore) or α -tubulin (Sigma-Aldrich), for 1 h, followed by goat-anti mouse AlexaFluor-
594-conjugated-secondary antibody (Invitrogen) incubation, for 45 min in the dark. F-actin was stained for 
15 min with 0.5 μ M Phalloidin-FITC (Sigma-Aldrich), 0.1 M EGTA and 1 M MgSO4. Finally, nucleus was stained 
with 10 μ g/mL 4′ , 6-diamidino-2-phenylindole (DAPI) solution. Multiwell plate-based screening was performed 
with a Leica DMI6000 B inverted motorized fluorescence microscope (Leica Microsystems). Microscopic images 
are represented at 300× magnification.
Phagocytosis. Ready-made pHrodo green Staphylococcus aureus BioParticles Conjugate (1 μ m diame-
ter) (Invitrogen) were resuspended in PBS up to 1 mg/mL and gently vortexed and sonicated for homogenous 
dispersion. Non-irradiated and 10 Gy irradiated macrophages (4 × 104) were then incubated with 1.6 × 106 S. 
aureus particles at 37 °C and 5% CO2, to evaluate phagocytic activity. After 1 h, macrophages were washed in 
PBS and fixed with 4% PFA for 20 min. For cell identification, F-actin was stained with rhodamine-labeled phal-
loidin (1:100 dilution) (Invitrogen) for 30 min, after previous permeabilization with 0.2% Triton X-100 and 5% 
bovine serum albumin (BSA) blocking. Finally, for nuclei visualization, macrophages were incubated with 10 μ g/
mL DAPI solution for 5 min. Multiwell plate-based screening was performed with IN Cell Analyzer 2000 (GE 
Healthcare). Microscopic images are represented at 150× magnification. The number of cells able to phagocyte S. 
aureus particles was then determined, using Fiji software66.
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Gelatin zymography. Macrophage CM (1 and 15 μ g of protein), collected 24 h after 10 Gy cumulative ion-
izing radiation exposure, were used to evaluate MMP-2 and MMP-9 activities, through gelatin-zymography, as 
previously described64.
Matrigel invasion assays. To evaluate macrophage-mediated RKO cell invasion, non-irradiated or 10 Gy 
irradiated RKO cells (5 × 104) were seeded on the upper compartment of Matrigel-coated inserts of 8-μ m pore 
size (BD Biosciences), while non-irradiated or 10 Gy irradiated macrophages (2 × 105), were added on the bot-
tom, for 24 h, as previously described64.
Chick embryo in vivo angiogenesis assay. The chick embryo CAM model was used to evaluate 
RKO-induced angiogenic response in the presence of macrophage CM. Therefore, commercially available ferti-
lized chick (Gallus gallus) eggs were horizontally incubated at 37.5 °C, in a humidified atmosphere. On embryonic 
development day (EDD)3, a square window was opened in the shell after removal of 1.5–2 mL of albumen, to 
allow detachment of the developing CAM. The window was sealed with a transparent adhesive tape and eggs 
re-incubated. On EDD10, RKO cells (1 × 106) resuspended in CM from non-irradiated or 10 Gy irradiated mac-
rophages were placed on top of the same CAM, into two independent 3 mm silicone rings, under sterile con-
ditions. For control, RKO cells resuspended in RPMI medium were inoculated in a different egg. Eggs were 
re-sealed and returned to the incubator for additional 72 h. On EDD13, rings were removed, the CAM was 
excised from embryos and photographed ex-ovo under a stereoscope, using a 20× magnification (Olympus, 
SZX16 coupled with a DP71 camera). The number of new vessels (< 20 μ m diameter) growing radially towards 
the inoculation area was counted in a blind fashion.
Statistical analysis. All graphs and statistical analysis were performed using GraphPad Prism Software v5 
(GraphPad-trial version). Data was analysed for Gaussian distribution using the D’Agostino and Pearson normal-
ity test, when n ≥ 8. To test the hypothesis that irradiated macrophages are different from non-irradiated ones, 
Wilcoxon matched pairs test was used for non-parametric samples, while t-test (either paired t-test or one sample 
t-test) was used for parametric data or when n < 8. For other comparisons, one-way ANOVA test was performed. 
Statistical significance was achieved when P < 0.05.
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